newest digital coin Knowledge

Australian Treasury Secretary chalmers: The new A $2 billion expenditure on natural disaster preparedness will affect the mid-year economic and financial outlook."Nature" announced the top ten figures in 2024, and two China scientists were selected. On the 9th, the website of the British magazine "Nature" released the list of the top ten figures promoting scientific development in 2024. Among them, two China scientists were selected. The list was compiled by the editors of Nature magazine to record the important scientific progress, events and some key figures this year. Among them, two China researchers who were selected as the top ten were Xu Huji, a rheumatologist from the PLA Naval Medical University, and Li Chunlai, deputy chief designer of the Chang 'e VI mission and a researcher at the National Astronomical Observatory of the Chinese Academy of Sciences. Dr. Xu Huji bravely tried to treat autoimmune diseases with CAR-T cell therapy, which brought hope for the mass production of CAR-T cell therapy. Li Chunlai was a key figure in determining the landing site of Chang 'e-6 probe on the moon, and was also one of the first scientists to analyze the returned samples.Heavy meeting set the tone! The turnover of A-shares exceeded one trillion yuan for 50 consecutive trading days, focusing on the opportunities of core assets of A50ETF Huabao (159596). On December 10th, the A-share market rose across the board, and the turnover of Shanghai and Shenzhen stock markets exceeded one trillion yuan for the 50th consecutive trading day, setting a new record. By midday, A50ETF Huabao (159596) had increased by 1.98%, with a turnover of 101 million yuan. In terms of constituent stocks, the top ten awkward stocks rose more and fell less. CITIC Securities led the gains, and China Ping An, China Merchants Bank and other stocks followed suit. According to changjiang securities's analysis, "moderately loose monetary policy" indicates abundant liquidity and broad-spectrum interest rate is still in the downward channel, which is expected to benefit bonds and stocks from the denominator. The "more active fiscal policy" and "all-round expansion of domestic demand" indicate that the broad credit policy is expected to continue to increase, and it is expected to support the price of equity assets from the molecular side.

Morgan Stanley published a research report that Jingdong Logistics management predicted that the net profit growth in FY 2024 would increase by 49% year-on-year, far exceeding the bank's expected 30% increase. As for the profit growth forecast for next year, it is 9% year-on-year. The bank also believes that the acquisition of Jingdong Logistics across the remaining rights and interests of Express is positive and is expected to have further synergy. Morgan Stanley set the target price of H shares of Jingdong Logistics at HK$ 13.1, giving it a rating of "keeping pace with the market".The investment of Shanghai private equity venture capital industry in the first three quarters was 45.947 billion yuan, a year-on-year decrease of 50%. On December 10th, at the 17th Bund Finance Shanghai International Equity Investment Forum, the development report of Shanghai private equity venture capital industry in 2024 was officially released. According to the report, in the first three quarters of 2024, there were 327 investments in Shanghai private equity venture capital industry, a year-on-year decrease of 47%; The total investment was 45.947 billion yuan, a year-on-year decrease of 50%. All rounds of financing activities have decreased, especially the A+ round, B round, D round and private placement round. The report also shows that in the first three quarters of 2024, the total amount of investment subscribed by Shanghai LP was about 67 billion yuan, a year-on-year increase of 15.61%; A total of 301 LPs were invested, a year-on-year decrease of 50.25%.Dotinolole, a new drug used by Weicai to treat gout, was approved for marketing in China. On December 10th, Weicai China announced that its new urate reuptake inhibitor Dotinolole tablets (trade name: Youlesi) had been approved by National Medical Products Administration (NMPA) in China, and its indication was gout with hyperuricemia.

The scientific and technological innovation sector is ready to go! Kechuang 100TF (588190) rose by 2.99% at midday, and Stevie rose by 6.20%. By midday on December 10th, Kechuang 100TF (588190) rose by 2.99%, with a turnover of 457 million yuan. Component stocks rose strongly, with Sitway rising by 6.20%, Guo Dun Quantum, Hengxuan Technology, Ruichuang Micro-Nano and Alice rising by over 3%, and Xinyuanwei and Anji Technology rising by over 2%. Guotai Junan said that the policy is set to be unconventional, the New Year's market is expected to continue, and the China stock market's transformation bull is taking shape, and its style and industry configuration are welcoming the "transformation bull" and its chess eyes are growing. Zhongtai Securities said that the meeting pointed out that "a more active fiscal policy and a moderately loose monetary policy should be implemented". The statement that monetary policy is "moderately loose" is the first time in many years, which indicates that a more powerful monetary policy tool will be used next year, but it does not mean relaxing the goal of stabilizing exchange rate and currency value. The easing of monetary policy throughout the year is still closely related to Trump's tax cuts, inflation and debt. Next year is the closing year of the "14th Five-Year Plan", which is the real main line of the technology and direction related to industrial policy or the "year-end and early year" market.Australian Treasury Secretary chalmers: We will hold consultations with the Shadow Minister on the composition of the new Reserve Bank of Australia. Substantial progress has been made in fighting inflation.Huang Wentao of China CITIC Construction Investment Co., Ltd. and others: It is estimated that deficit ratio will rise to over 4% in 2025, and it is expected that the stock and debt will continue. On December 9th, the Political Bureau of the Central Committee held a meeting to analyze and study the economic work in 2025. Huang Wentao, chief economist of CITIC Jiantou, and Liu Tianyu, macro analyst of CITIC Jiantou, believe that the policy tone of this Politburo meeting is quite proactive, which shows that the central government has made a full assessment and policy reserve for the pressures and risks that may be encountered in economic development next year, which has strongly echoed the expectations of economic entities. Huang Wentao and Liu Tianyu pointed out that GDP growth in the fourth quarter is expected to reach more than 5.2%, achieving the expected goal of annual economic growth of around 5%. On this basis, the annual growth target of about 5% will also be the basic premise of policy discussion in the next few years. Since the fourth quarter of this year, the fiscal policy has been continuously overweight. This time, the fiscal policy is set to be "more active", which indicates that the fiscal policy will expand again. It is estimated that deficit ratio will increase to over 4% in 2025. Both stocks and debts are expected to continue. Unconventional countercyclical adjustment policies not only provide sufficient impetus for the recovery of economic vitality, but also provide strong support for improving expectations and reviving confidence, and provide sufficient source of living water for the capital market. The stock market is expected to continue to strengthen and the risk-free rate of return is expected to continue to decline.